Arrowhead Pharma (ARWR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 09-2025 | 09-2024 | 09-2023 | 09-2022 | 09-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 30,114 | -609,693 | -209,275 | -176,494 | -140,848 |
| Depreciation Amortization | 18,139 | 15,351 | 10,476 | 13,331 | 8,533 |
| Accounts receivable | -56,967 | N/A | 1,410 | 8,845 | -9,409 |
| Accounts payable and accrued liabilities | 6,286 | -5,536 | 32,998 | -6,589 | 2,628 |
| Other Working Capital | -18,235 | 25,091 | -51,547 | -98,293 | 228,662 |
| Other Operating Activity | 200,215 | 111,936 | 62,048 | 123,069 | 81,746 |
| Operating Cash Flow | $179,552 | $-462,851 | $-153,890 | $-136,131 | $171,312 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -796,258 | -720,947 | -246,141 | -223,391 | -240,703 |
| PPE Investments | -22,666 | -141,469 | -176,737 | -52,777 | -23,567 |
| Sale Of Investment | 689,630 | 442,344 | 326,723 | 270,751 | 122,592 |
| Investing Cash Flow | $-129,294 | $-420,072 | $-96,155 | $-5,417 | $-141,678 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 10,260 | N/A | N/A | N/A | N/A |
| Debt Issued | N/A | 392,000 | N/A | 60,000 | N/A |
| Debt Repayment | -201,625 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 270,371 | 431,654 | 3,053 | 5,186 | 11,305 |
| Other Financing Activity | -5,000 | 46,866 | 250,000 | 0 | 0 |
| Financing Cash Flow | $74,006 | $870,520 | $253,053 | $65,186 | $11,305 |
| Exchange Rate Effect | -401 | 4,197 | -122 | -67 | -88 |
| Beginning Cash Position | 102,685 | 110,891 | 108,005 | 184,434 | 143,583 |
| End Cash Position | 226,548 | 102,685 | 110,891 | 108,005 | 184,434 |
| Net Cash Flow | $123,863 | $-8,206 | $2,886 | $-76,429 | $40,851 |
| Free Cash Flow | |||||
| Operating Cash Flow | 179,552 | -462,851 | -153,890 | -136,131 | 171,312 |
| Capital Expenditure | -22,666 | -141,469 | -176,737 | -52,777 | -23,567 |
| Free Cash Flow | 156,886 | -604,320 | -330,627 | -188,908 | 147,745 |